Assignee
AMPEL BIOSOLUTIONS LLC
US·1 granted patent·15 pending applications·0 citations·filing 2019–2025
Top patents by PatentIndex Score
16 records- 0166US2025078957A1Unsupervised Machine Learning MethodsAMPEL BIOSOLUTIONS LLC·Filed 2024·Application pending·0 cites
- 0266US2025022541A1Unsupervised Machine Learning MethodsAMPEL BIOSOLUTIONS LLC·Filed 2024·Application pending·0 cites
- 0366US2024428948A1Unsupervised Machine Learning MethodsAMPEL BIOSOLUTIONS LLC·Filed 2024·Application pending·0 cites
- 0459US2025174366A1Methods and Compositions for Assessing and Treating LupusAMPEL BIOSOLUTIONS LLC·Filed 2024·Application pending·0 cites
- 0556US2024363249A1Machine Learning Disease Prediction and Treatment PrioritizationAMPEL BIOSOLUTIONS LLC·Filed 2024·Application pending·0 cites
- 0653US2025182844A1Methods for Identifying Shared Biological Pathways Between Diseases Using Mendelian RandomizationAMPEL BIOSOLUTIONS LLC·Filed 2024·Application pending·0 cites
- 0748US2025006370A1Systems and Methods for Analysis of Patient-Reported Outcome DataAMPEL BIOSOLUTIONS LLC·Filed 2022·Application pending·0 cites
- 0847US2025336533A1Methods and Systems for Evaluation of Lupus Based on Ancestry-Associated Molecular PathwaysAMPEL BIOSOLUTIONS LLC·Filed 2025·Application pending·0 cites
- 0945US2024282449A1Methods and systems for machine learning analysis of inflammatory skin diseasesAMPEL BIOSOLUTIONS LLC·Filed 2022·Application pending·0 cites
- 1043US2025391505A1Methods and Systems for Machine Learning Analysis of Lupus NephritisAMPEL BIOSOLUTIONS LLC·Filed 2025·Application pending·0 cites
- 1141US2025011886A1Systems and Methods for Targeting COVID-19 TherapiesAMPEL BIOSOLUTIONS LLC·Filed 2022·Application pending·0 cites
- 1241US2024076745A1Machine learning classification of lung nodules based on gene expressionAMPEL BIOSOLUTIONS LLC·Filed 2021·Application pending·0 cites
- 1340US12548678B2Methods and systems for machine learning analysis of single nucleotide polymorphisms in lupusAMPEL BIOSOLUTIONS LLC·Filed 2021·Granted Feb 10, 2026·0 cites·20 claims
- 1437US2023220470A1Methods and systems for analyzing targetable pathologic processes in covid-19 via gene expression analysisAMPEL BIOSOLUTIONS LLC·Filed 2021·Application pending·0 cites
- 1537US2020090787A1Systems and methods for single-cell rna-seq data analysisAMPEL BIOSOLUTIONS LLC·Filed 2019·Application pending·0 cites
- 1636US2021104321A1Machine learning disease prediction and treatment prioritizationAMPEL BIOSOLUTIONS LLC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →